Zealand Pharma A/S Appoints Ivan Møller as Senior Vice President, Technical Development & Operations, Effective March 1, 2018
January 19, 2018 at 03:09 am EST
Zealand Pharma A/S announced the appointment of Ivan Møller to a new position as Senior Vice President, Technical Development & Operations. Ivan Møller is joining Zealand as a new member of Management with effect from March 1, 2018. Prior to joining Novartis, Ivan Møller was project leader at The Boston Consulting Group in New York, NY where he led client engagements in the pharmaceutical R&D and manufacturing areas. He started his career at PolyPeptide Laboratories where he was Head of Production site. Ivan Møller is a dual American /Danish citizen.